AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD

BACKGROUND: AMPLIFY assessed the efficacy and safety of aclidinium bromide/formoterol fumarate (AB/FF) vs its monocomponents and tiotropium (TIO) in patients with moderate-to-very severe symptomatic COPD (NCT02796677). METHODS: In this 24-week, Phase III, double-dummy, active-controlled study, sympt...

詳細記述

保存先:
書誌詳細
出版年:Int J Chron Obstruct Pulmon Dis
主要な著者: Sethi, Sanjay, Kerwin, Edward, Watz, Henrik, Ferguson, Gary T, Mroz, Robert M, Segarra, Rosa, Molins, Eduard, Jarreta, Diana, Garcia Gil, Esther
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2019
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6435124/
https://ncbi.nlm.nih.gov/pubmed/30962681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S189138
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料